3643companies in the directory 1104ISIN verified against the check digit 7exchanges 14sectors No real-time quotes — a reference work, not a trading platform3643companies in the directory 1104ISIN verified against the check digit 7exchanges 14sectors No real-time quotes — a reference work, not a trading platform
DE · EN Newsletter
Biotech & Pharma Symbolbild · KI-generiert
Biotech & Pharma IDL

Imaging Dynamics Company Ltd.

IDL TSXV Biotech & Pharma

Stock factsheet

TickerIDL
ExchangeTSXV
ISIN
WKN
SectorBiotech & Pharma
Size class Nano Cap
Market capitalisation 552.540 USD As of 2026-08-04

Company data from public sources (TMX Money, Canadian Securities Exchange, Nasdaq screener, Wikidata); every ISIN is verified against its check digit. Where „—“ appears, no verified value exists — we do not publish unverified identifiers. Market capitalisation is an order of magnitude as of the date shown, not a real-time figure. The size class follows the thresholds in common use (micro < $300m, small < $2bn, mid < $10bn) and is meant as an indication, not a definition.

Company profile

Imaging Dynamics Co Ltd manufacturer of medical imaging devices. Its products include 1600Plus X-series, Veterinary DR System, Magellan medical image processing software, Sirius Veterinary image processing software, CCD technology, Aquarius 8600, and VetnovaXion DR series. It sells primarily through dealers, distributors and OEM partners. The company has sales in two sales geographic areas within one operating segment consisting of the Americas and outside of the Americas.

Company description as published by the issuer via TMX Money.

Comparable companies

Companies in the Biotech & Pharma sector of a similar size.

CompanyTickerExchangeMarket cap
Imaging Dynamics Company Ltd.IDL TSXV552.540 USD
Waverley Pharma Inc. WAVETSXV 577.425 USD
Entheon Biomedical Corp. ENBI.XCSE 592.777 USD
Element Lifestyle Retirement Inc. ELMTSXV 502.419 USD
Vaxil Bio Ltd. VXLTSXV 497.016 USD
Mary Agrotechnologies Inc MARYCSE 614.892 USD
Vencanna Ventures Inc. VENICSE 648.681 USD

Investor Relations

Annual reports Not recorded yet
Investor presentation Not recorded yet
Analyst coverage Not recorded yet

We link only to primary sources from the company itself and from the regulators. Fields we have not recorded stay empty until a reliable source is available.

Information and education only — not investment advice, not a recommendation and not a financial analysis within the meaning of §85 WpHG or Art. 20 MAR. Investments in small and micro caps are highly speculative; total loss is possible. All information without warranty.